Aiming to launch ambitious joint projects of high international standard between Indian and Spanish organisations, India and Spain will soon begin collaborative programmes in the field of biotechnology under the Indo-Spanish programme for technological co-operation in the field of biotechnology.
The objective of the joint Indo-Spanish programme is to promote and fund market-driven research and technology development as well as to encourage partnerships and business-led research and development (R&D) collaborative projects in the field of biotechnology.
The programme is open to collaborative R&D projects in all areas of biotechnology e.g. health biotechnology, industrial biotechnology, nano-biotechnology, agro-biotechnology, including biofuels and bioenergy, bioinformatics and biomedical engineering. Potential projects will be funded by Department of Biotechnology of India (DBT) in India and the Centre for the Development of Industrial Technology (CDTI) in Spain.
Minimum eligibility criteria for the programme included at least one qualified partner from India and one qualified partner from Spain. From the Spanish side the project must necessarily be led by a company. Collaboration with other Spanish R&D entities (research institutes, academic institutions, technology centres) is permitted. The Indian side of the consortium can either be led by a company or a research institution.
The joint programme for co-operation between the DBT and the CDTI was signed by on November 22, 2011. The DBT and the CDTI are the nodal implementing agencies from the Indian and Spanish side respectively.
DBT is the nodal agency under the Ministry of Science and Technology for the promotion of research, development and innovation in the field of biotechnology. DBT funds and supports all Indian universities, research organisations, non-governmental organisations and industry working in the area of biotechnology.
The CDTI is a Public Entity, part of the Ministry of Economy and Competitiveness, Government of Spain, which fosters the technological development and innovation of Spanish Companies. Since 2009, it has been the entity that channels and supports applications for national and international R&D&I projects of Spanish Companies.
Source:Pharmabiz
The objective of the joint Indo-Spanish programme is to promote and fund market-driven research and technology development as well as to encourage partnerships and business-led research and development (R&D) collaborative projects in the field of biotechnology.
The programme is open to collaborative R&D projects in all areas of biotechnology e.g. health biotechnology, industrial biotechnology, nano-biotechnology, agro-biotechnology, including biofuels and bioenergy, bioinformatics and biomedical engineering. Potential projects will be funded by Department of Biotechnology of India (DBT) in India and the Centre for the Development of Industrial Technology (CDTI) in Spain.
Minimum eligibility criteria for the programme included at least one qualified partner from India and one qualified partner from Spain. From the Spanish side the project must necessarily be led by a company. Collaboration with other Spanish R&D entities (research institutes, academic institutions, technology centres) is permitted. The Indian side of the consortium can either be led by a company or a research institution.
The joint programme for co-operation between the DBT and the CDTI was signed by on November 22, 2011. The DBT and the CDTI are the nodal implementing agencies from the Indian and Spanish side respectively.
DBT is the nodal agency under the Ministry of Science and Technology for the promotion of research, development and innovation in the field of biotechnology. DBT funds and supports all Indian universities, research organisations, non-governmental organisations and industry working in the area of biotechnology.
The CDTI is a Public Entity, part of the Ministry of Economy and Competitiveness, Government of Spain, which fosters the technological development and innovation of Spanish Companies. Since 2009, it has been the entity that channels and supports applications for national and international R&D&I projects of Spanish Companies.
Source:Pharmabiz
No comments:
Post a Comment